Skip to main content
Full access
Letter to the Editor
Published Online: 1 November 1998

Response of the Parkinsonian Symptoms of Multiple System Atrophy to ECT

Publication: American Journal of Psychiatry
To the Editor: Multiple system atrophy is a sporadic degenerative disorder characterized by parkinsonism, dysautonomia, and ataxia in any combination (1). The parkinsonian symptoms of multiple system atrophy are poorly responsive to levodopa therapy (2), unlike Parkinson"s disease in which the motoric symptoms respond to dopaminergic agents and ECT. We present a case report of a patient with multiple system atrophy and comorbid major depression whose parkinsonian symptoms responded to ECT.
Mr. A was a 78-year-old man who at the age of 72 had developed bradykinesia, rigidity, resting tremor, ataxia, ortho­static hypotension, and urinary incontinence. His parkinsonian symptoms were poorly responsive to carbidopa and levodopa; Mr. A was unable to transfer (i.e., move from his bed to a chair) or walk independently. At the age of 75, he had developed antidepressant-refractory major depression.
Following outpatient neurology and psychiatric evaluations, Mr. A was referred for inpatient psychiatric treatment. Upon admission, he reported a depressed mood, anhedonia, anergia, frequent nocturnal awakenings, decreased appetite, feelings of guilt, and a fixed belief that “people were plotting” against him. His score on the Mini-Mental State examination) was 27 of 30; on the Hamilton Rating Scale for Depression, his score was 41. Mr. A’s diagnosis was major depression with psychotic features; following informed consent, he received eight bilateral ECT treatments (EEG seizure duration=409 seconds) without complication. Carbidopa and levodopa (25 and 100 mg, respectively; two and one-half tablets q.i.d) were continued throughout the ECT course. Following the second treatment, improvement in bradykinesia was noted. After the fifth treatment, Mr. A was reevaluated by the neurology service, and the degree of rigidity, resting tremor, and gait instability was improved. Specifically, Mr. A was able to transfer himself from one position or station to another and walk with minimal assistance. Improvement in his parkinsonian symptoms occurred before the antidepressant effects of ECT were clinically evident. His post-ECT scores on the Mini-Mental State and the Hamilton depression scale were 24 of 30 and 7, respectively. Six bilateral maintenance ECT treatments were administered during the 4 months following discharge. Improvement in parkinsonian symptoms was sustained, and Mr. A was able to transfer himself from one position or station to another and walk independently.
To our knowledge, this represents the first case report where the parkinsonian symptoms of multiple system atrophy responded to treatment with ECT. In a MEDLINE search, one previous case report was identified in which ECT was used to treat combined multiple system atrophy and major depression (3). In this report, the patient "s depression responded to 10 right unilateral (nondominant) ECT treatments (EEG seizure duration=462 seconds), but there was no improvement in his parkinsonian symptoms. It was speculated that bilateral ECT may have been more effective and further postulated that putaminal postsynaptic dopaminergic dysfunction renders the parkinsonian symptoms of multiple system atrophy refractory to treatment with ECT.

References

1.
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. J Neurol Sci 1996; 144:218–219
2.
Parati EA, Fetoni V, Geminiani GC, Soliveri P, Giovannini P, Testa D, Genitrini S, Caraceni T, Girotti F: Response to L-DOPA in multiple system atrophy. Clin Neuropharmacol 1993; 16:139–144
3.
Ruxin RJ, Ruedrich S: Case report and review: ECT in combined multiple system atrophy and major depression. Convuls Ther 1994; 10:298–300

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1626d - 1626

History

Published online: 1 November 1998
Published in print: November 1998

Authors

Affiliations

W. MICHAEL HOOTEN, M.D.
JARRETT W. RICHARDSON, M.D.
Rochester, Minn.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share